Pharmaceuticals: United States

Report Overview

Pharmaceuticals: United States

This report forecasts to 2028 US (including Puerto Rico) pharmaceutical demand and shipments for human use in nominal US dollars at the manufacturer level. Total demand is segmented by product in terms of: compounded and biological. Compounded pharmaceutical demand is also segmented by therapeutic class as follows: hormones and related, central nervous system, anti-infective, cardiovascular, nutritional, respiratory, dermatological, and digestive and genito-urinary.

To illustrate historical trends, total demand, total shipments, trade, and the various segments are provided in annual series from 2013 to 2023.

To avoid double-counting, uncompounded pharmaceuticals, also referred to as pharmaceutical chemicals or ingredients, are excluded from the scope of this report. Diagnostic, industrial, and veterinary products are also excluded. Re-exports of pharmaceuticals are excluded from demand and trade figures.

Key macroeconomic indicators are also provided with quantified trends. Other various topics, including profiles of pertinent leading companies, are covered in this report. A full outline of report items by page is available in the Table of Contents.

Related NAICS Codes:

• 325412 Pharmaceutical Preparation Mfg
• 325414 Biological Product (except Diagnostic) Mfg